QuidelOrtho Corporation (QDEL) Releases Q4 2025 Earnings: Revenue Slightly Above Estimates but EPS Miss

QuidelOrtho Corporation (QDEL) reported fourth-quarter 2025 results. Revenue was $723.6 million, up 2.23% year-over-year and slightly above the consensus estimate of $722.6 million. Diluted earnings per share were -1.92, missing the estimate of 0.4316.

Gross profit: $320.4 million (-1.75% YoY)

Cost of sales: $403.2 million (+5.63% YoY)

Operating loss: -$66.3 million (-33.96% YoY)

Net loss attributable to common shareholders: -$130.7 million (-26.74% YoY)

Diluted EPS: -1.92 (down 15.79% YoY)

Cash from operating activities: $131.9 million (+107.06% YoY)

Purchases of property, plant and equipment: $49.2 million (+4.24% YoY)

Cash and cash equivalents: $169.8 million (+72.74% YoY)

Total liabilities: $3.85 billion (+11.91% YoY)

Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.

QuidelOrtho Corporation Insider Trading Activity

QuidelOrtho Corporation insiders have traded $QDEL stock on the open market 6 times in the past 6 months. Of those trades, 5 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $QDEL stock by insiders over the last 6 months:

BRIAN J. BLASER (President and CEO) purchased 23,500 shares for an estimated $501,576
JOSEPH M. BUSKY (Chief Financial Officer) purchased 4,770 shares for an estimated $124,305
KENNETH J WIDDER sold 4,026 shares for an estimated $111,965
MARY LAKE PH D POLAN purchased 1,000 shares for an estimated $22,430
ANN D RHOADS purchased 750 shares for an estimated $21,206
JOSEPH D JR. WILKINS purchased 370 shares for an estimated $10,343

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

QuidelOrtho Corporation Hedge Fund Activity

We have seen 123 institutional investors add shares of QuidelOrtho Corporation stock to their portfolio, and 153 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FMR LLC added 1,880,691 shares (+71.9%) to their portfolio in Q3 2025, for an estimated $55,386,349
AQR CAPITAL MANAGEMENT LLC removed 1,572,740 shares (-86.5%) from their portfolio in Q3 2025, for an estimated $46,317,193
D. E. SHAW & CO., INC. removed 1,468,178 shares (-73.2%) from their portfolio in Q3 2025, for an estimated $43,237,842
INVESCO LTD. added 1,352,503 shares (+87.0%) to their portfolio in Q3 2025, for an estimated $39,831,213
NEWTYN MANAGEMENT, LLC added 994,332 shares (+58.3%) to their portfolio in Q3 2025, for an estimated $29,283,077
ESTUARY CAPITAL MANAGEMENT LP added 970,886 shares (+inf%) to their portfolio in Q3 2025, for an estimated $28,592,592
GOLDMAN SACHS GROUP INC added 883,077 shares (+101.2%) to their portfolio in Q4 2025, for an estimated $25,220,679

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

QuidelOrtho Corporation Analyst Ratings

Wall Street analysts have issued reports on $QDEL in the last several months. We have seen 0 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

JP Morgan issued a "Underweight" rating on 11/07/2025

To track analyst ratings and price targets for QuidelOrtho Corporation, check out Quiver Quantitative's $QDEL forecast page.

QuidelOrtho Corporation Price Targets

Multiple analysts have issued price targets for $QDEL recently. We have seen 3 analysts offer price targets for $QDEL in the last 6 months, with a median target of $33.0.

Here are some recent targets:

Lu Li from UBS set a target price of $35.0 on 01/21/2026
Casey Woodring from JP Morgan set a target price of $22.0 on 11/07/2025
Patrick Donnelly from Citigroup set a target price of $33.0 on 10/07/2025